Breaking: FDA restricts J&J’s COVID vaccine

The Food and Drug Administration strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.

If you are having trouble viewing this email, click here.

MAY 5, 2022 FDA restricts J&J's COVID-19 vaccine due to blood clot risk   The Food and Drug Administration strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. Read More Advertisement

The email address for your subscription is moroccaninuae.note@blogger.com Manage Email Preferences For more New York Post, download the New York Post App: Follow us on:   New York Post 1211 Avenue of the Americas New York, NY 10036 USA © Copyright 2022 NYP Holdings, Inc. All rights reserved Privacy | Terms of Use | Your Ad Choices | Unsubscribe from All If you believe this has been sent to you in error, please safely unsubscribe.